RESEARCH-USE BIOSIMILAR ANTIBODY

Miromavimab

Monoclonal antibody · IgG1

Rabies Virus Strain ERA GP Ectodomain Epitope G-IIIgG1RUO

Miromavimab (M777-16-3) is a anti-rabies virus strain ERAGP ectodomainepitope G-II mAb.

TARGETRabies Virus Strain ERA GP Ectodomain Epitope G-II
YMonoclonal antibody
CATALOGSC-BS-371
CATALOG NUMBERSC-BS-371
MOLECULAR WEIGHTLot-specific
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Miromavimab (M777-16-3) is a anti-rabies virus strain ERAGP ectodomainepitope G-II mAb.

Miromavimab is a recombinant research-use antibody directed against Rabies Virus Strain ERA GP Ectodomain Epitope G-II.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Miromavimab | StellaCyte